Genetic Engineering & Biotechnology News: 'Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus...'

From the November 15 posting:

"In a strategic effort to refocus and strengthen its organization, the Fitzsimons Redevelopment Authority (FRA) has completed a regimen of planning to make adjustments in the direction, roles, responsibilities and allocation of resources going forward. The announcement is made by Denise Brown, FRA Interim Executive Director, who says, 'Our first tactic in refocus involves augmenting our board of directors with four of the area's most well-known and successful leaders in the bioscience industry.'

Joining the FRA Board are Donald M. Elliman, Jr., Executive Director of the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and current Director and former Chair of the Children's Hospital Colorado Board of Directors; William Freytag, PhD, former Chairman and CEO of Myogen, Inc.; James C. T. Linfield, Partner-in-Charge of the Colorado office of Cooley LLP; and David Perez, President and Chief Executive Officer of CaridianBCT, becoming TerumoBCT."

Link to GEN

Fitzsimons Redevelopment Authority Rolls Out 1st Phase of Strategic Refocus With Appointment of Four Key Leaders in Bioscience Industry to Its Board

In a strategic effort to refocus and strengthen its organization, the Fitzsimons Redevelopment Authority (FRA) has completed a regimen of planning to make adjustments in the direction, roles, responsibilities and allocation of resources going forward. The announcement is made by Denise Brown, FRA Interim Executive Director, who says, "Our first tactic in refocus involves augmenting our board of directors with four of the area's most well-known and successful leaders in the bioscience industry to help build programs and services to attract bioscience companies to relocate to Colorado and keep growing Colorado-based bioscience companies here, adding to our employment base. Modifying the board accordingly was approved in a recent board action."

Joining the FRA Board are (pictured L-R above): Donald M. Elliman, Jr., Executive Director of the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and current Director and former Chair of the Children's Hospital Colorado Board of Directors; William Freytag, PhD, former Chairman and CEO of Myogen, Inc.; James C. T. Linfield, Partner-in-Charge of the Colorado office of Cooley LLP; and David Perez, President and Chief Executive Officer of CaridianBCT, becoming TerumoBCT.

Brown continues, "We're very pleased to welcome our new board members. These leaders are actively involved the bioscience community - locally, nationally and internationally - and maintain those critical relationships with entrepreneurs, companies and research groups required to guide the FRA through its next phase of growth. This is the first time the FRA has had bioscience executives on its board."

Link to the PR Web Newswire

Link to the Pitch Engine Social Media Release

Photo Exhibit By Colorado Bioscience Awards Keynote Rick Guidotti Opens 11/18 At Santa Fe Arts District VSA Colorado/Access Gallery

Photos by Colorado BioScience Association (CBSA) Awards Dinner Keynote Speaker Rick Guidotti will be on display for the general public beginning November 18 (through December 16) at the VSA Colorado/Access Gallery in Denver's Santa Fe Arts District. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “We are very pleased that everyone in the community will have the opportunity to see Rick's powerful images about genetic difference."

View a video about Rick Guidotti's Positive Exposure and its mission:



http://youtu.be/_-cMu3UA4QE

Link to the Business Wire Release

Link to the Pitch Engine Social Media Newswire

Colorado BioScience Association Launches Internship Program With Support of 11 Employers + Area Universities

The CBSA is launching its new Internship Program with the support of 11 founding employers in the Denver area. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “Our education committee has been working diligently with our member companies and universities for the past six months to develop a program that will be valuable to both the student interns and participating companies as we go forward. We will begin intern recruitment immediately through early spring 2012 with the first interns expected to be placed in positions by summer 2012."

Participating employers, at program launch, include:

* Allosource
* Amgen
* Baxa Corporation
* CaridianBCT, Becoming TerumoBCT
* Colorado BioScience Association
* Colorado Institute for Drug, Device and Diagnostic Development (CID4)
* GlobeImmune
* Merck
* Sandhill Scientific
* Sharklet Technologies
* Tolmar

"In addition to these 'founding employers,' we've had interest from yet another six companies. Our team has been very pleased with the positive response from both employers and our universities," Mark Spiecker, President & CEO of Sharklet Technologies and Chair of the CBSA Education Committee, explains. "Now more than ever, there's an extreme need for university students to obtain real world experience, in addition to their time in the classroom."

Link to the Business Wire Release

Link to the Pitch Engine Social Media Release

Fall Cat Care Quarterly: Hot Off The Press and Soon, If Not Already, In Your Mailbox

Cat Rescue: Joplin Cats Find Their Way to CCS

Adoption Tips: Communicating With Your Cat (Part 2)

Dr. Lynne: Can Your Cat Say Cheese? (and look good at the same time?)

Tails of the Painted Cats 2012

Cupcakes for Cats Recap

Memorials

Scratching Post

And More...

Link to read the new Fall issue online

Link to receive Cat Care Society's e-newsletter

Donate online to help our Cat Care Society kitties - every bit helps at the shelter!

Love Wine? Love Cats? Now Indulge Both and Help Cat Care Society!

Just in time for Holiday gifting and gathering: Cat Care Society has partnered with Benefit Wines to raise funds with its new "Cat Care Vineyards" selection of wines:

Love Me Malbec - A medium bodied and soft Malbec will delight with plums, leather and chocolate overtones. With well balanced acidity it provides a juicy and easy drinking wine.

Prowlin' Pinot - Layers of ripe red fruit flavors are among the distinctive features of this elegant varietal. It's fresh on the palate, with a long, lingering finish.

Kitten Kabernet - Rich and ripe this Cabernet features ripe berry aromas and an intensely fruity character. Smooth and well structured, it has soft velvety tannins on the finish.

Cotton Chardonnay - Lively and unoaked, this crisp, medium-bodied wine has lovely straw-yellow hues and aromas of apricots, apples and tropical fruits.

Benny's Select Merlot - This estate grown, handcrafted merlot shows a deep red color with aromas of black pepper and ripe red fruit. Soft and well balanced this merlot displays all the characteristics of the varietal.

SHHH-auvignon Blanc - This crisp, mouth-watering wine captivates with refreshing tropical and citrus fruit flavors, and a clean, well-balanced finish.

All are certified organic and vegan friendly.

Link to learn more and order individual bottles or the Collector's and Sampler packages. A portion of each purchase benefits Cat Care Society - see product descriptions.

Ariel Pharma Only Colorado Life Science Company Presenting at Prestigious Silicon Valley Bank SVB Showcase Event

CBSA Board Chair Steve Orndorff, President & CEO of Ariel Pharmaceuticals, presented at Silicon Valley Bank's SVB Showcase, October 20 in Menlo Park, CA. Ariel was the only life science company from Colorado presenting to more than 200 investors at the conference. SVB Showcase 2011, hosted by the SVB Accelerator, featured three concurrent tracks with presentations from companies seeking a Series A, B or C round of financing in the life science, cleantech and technology sectors.

Here's video of Orndorff's SVB Showcase interview about Ariel Pharma:

http://youtu.be/iBqeHnRGvG0

Link to the Ariel Pharmaceuticals website

Link to the SVB - Silicon Valley Bank website